HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

BRKR

Bruker Corporation

Healthcare — Medical Devices

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Buy 2.1 / 5 12 analysts
$61.94
$-2.81 (-4.34%)
Target: $59.75 (-3.5%)

Price History

52-Week Range
Sign in to add BRKR to a watchlist or set price alerts.

Fundamentals

Market Cap$9.57B
P/E Ratio (TTM)-
Forward P/E25.87
EPS (TTM)$-0.24
Dividend Yield0.32%
Profit Margin-0.34%
Revenue Growth2.70%
ROE-0.43%
Debt/Equity68.12
Recommendation Buy 2.1
Analyst Target$59.75
Analysts12
Next Earnings Aug 4, 2026 BMO
Indexes -

Technical Indicators

RSI (14)58.3
Beta1.29
SMA 20$60.16
SMA 40$58.90
52-Week High$65.30
52-Week Low$28.53
50-Day Avg$57.56
200-Day Avg$45.78
Avg Volume$2.45M
Volume$1.68M

Performance Analysis

NEUTRAL

BRKR presents a mixed picture with both positive and negative indicators.

- Trading near its 52-week high ($65.30), which may indicate limited upside.
+ RSI at 58.3 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 2.7% year-over-year.
- Operating at a loss with -0.3% margin.
+ Wall Street consensus is "Buy" from 12 analysts.
- Average analyst target of $59.75 implies 3.5% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 05:07 UTC

Back to Screener Export Report